QuarterWatch Signals for Two Newly Approved Drugs: Dabigatran and Dalfampridine/Include Purpose on Rx/Use of Two Pumps Allows Bypass of Drug Library/Anesthesia Patient Safety Foundation Tackles Postoperative Opioid Monitoring/Lilly Updates Humulin R U-500 Label

Abstract

These medication errors have occurred in health care facilities at least once. They will happen again—perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them at your inservice training programs.

Your assistance is required to continue this feature. The reports described here were received through the Institute for Safe Medication Practices (ISMP) Medication Errors Reporting Program. Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below.

Errors, close calls, or hazardous conditions may be reported directly to ISMP through the ISMP Web site (www.ismp.org), by calling 800-FAIL-SAFE, or via e-mail at [e-mail]. ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications.